Advances in colon cancer detection: A huge potential lifesaver

By ACSH Staff — Aug 03, 2011
Though it claimed the lives of more than 50,000 Americans in 2010 alone, colon cancer is actually a largely preventable disease when people adhere to the recommended screening guidelines. According to the U.S. Preventive Services Task Force, there are three methods to choose from: either a colonoscopy performed about every ten years, a flexible sigmoidoscopy every five years, or an annual fecal occult blood test (FOBT) which can be performed at home.

Though it claimed the lives of more than 50,000 Americans in 2010 alone, colon cancer is actually a largely preventable disease when people adhere to the recommended screening guidelines. According to the U.S. Preventive Services Task Force, there are three methods to choose from: either a colonoscopy performed about every ten years, a flexible sigmoidoscopy every five years, or an annual fecal occult blood test (FOBT) which can be performed at home.

Although FOBT was long considered somewhat inferior to a colonoscopy, a newer version of it called immunochemical FOBT (iFOBT) is proving to be a marked improvement over older versions. The new test has 90 percent specificity for colon cancer and a false-positive rate of about 10 percent. Those were the results found in a study of 2,800 adults led by Dr. Yi-Chia Lee of the National Taiwan University Hospital and published in the Canadian Medical Association Journal.

However, iFOBT alone is far from a perfect diagnostic. Colonoscopies, unlike iFOBT, allow physicians not only to spot, but also to remove pre-cancerous growths called polyps so that they are therapeutic as well as diagnostic tools.

While acknowledging the improved diagnostic power of iFOBT, ACSH s Dr. Elizabeth Whelan is still convinced that undergoing a colonoscopy is a patient s best weapon against colon cancer. I understand that some people may be afraid of the procedure, she says, but it s so easy to prevent colon cancer and eliminate premature deaths by making sure that, if you re over the age of 50 or have risk factors, you get a colonoscopy as recommended by your physician.

ACSH's Dr. Gilbert Ross does point out, however, that compared to a colonoscopy, which can cost up to $3,000, an iFOBT runs only $30, so that an iFOBT is still indeed a valuable clinical tool. It may not be super sensitive or specific, he says, but if your regular annual iFOBT results are negative, you don t necessarily have to get a colonoscopy. And despite it s hassle, says Dr. Ross, a colonoscopy still remains the gold standard for colon cancer diagnosis and therapy.

ACSH relies on donors like you. If you enjoy our work, please contribute.

Make your tax-deductible gift today!

 

 

Popular articles